Moreover, genomic analyses have determined that SCLC tumors present extensive copy number alterations (CNAs) and high mutation rates, although SCLCs are not characterized by homologous recombination (HR) deficiency or mutations in BRCA1/2 [28,29]. The gene discussed is BRCA1; the disease is small cell lung carcinoma.